Emerging Neurodegenerative and Cardiovascular Biomarkers Fuel...

Ajouter une nouvelle offre d'emploi Domicile

2025-07-15 14:35:06 - Traduire

Emerging Neurodegenerative and Cardiovascular Biomarkers Fuel Growth in Specialized U.S. Segments

The U.S. biomarkers market was valued at USD 25.92 billion in 2024, with a projected CAGR of 15.16% expected from 2025 to 2034, driven by strong national policy impact, robust R&D leadership, and strategic positioning of leading global players. The U.S. remains the epicenter of biomarker innovation, supported by federal funding from agencies such as the National Institutes of Health (NIH),...

0 Commentaires 0 Parts 76 Vue 0 Aperçu